On Friday, Jumei International Holding Ltd (ADR) (NYSE:JMEI)’s shares declined -9.32% to $25.40.
Jumei International Holding Ltd (ADR) (JMEI) declared its unaudited financial results for the first quarter ended March 31, 2015.
First Quarter 2015 Highlights
- Net revenues raised by 61.8% year-over-year to US$250.6 million.
- Total net GMV [1]raised by 20.3% year-over-year to US$326.5 million, primarily due to a 14.3% enhance in the number of active customers[2] and an 18.4% enhance in total orders[3].
- Gross profit as a percentage of net revenues reduced to 31.4% from 44.1% in the same period of 2014. Gross profit as a percentage of total net GMV reduced slightly to 24.1% from 25.2% in the same period of 2014. The decrease was primarily due to the Company’s shift in strategy from beauty product marketplace sales to merchandise sales that started in September 2014.
- Net income attributable to Jumei’s ordinary shareholders raised by 49.5% to US$15.7 million from US$10.5 million in the same period of 2014. Net margin attributable to Jumei’s ordinary shareholders was 6.3%, contrast with 6.8% in the same period of 2014.
- Non-GAAP net income attributable to Jumei’s ordinary shareholders[4]was US$17.2 million, an enhance of 44.5% from the same period of 2014. Non-GAAP net margin attributable to Jumei’s ordinary shareholders[4] was 6.9%, contrast with 7.7% in the same period of 2014.
Jumei International Holding Limited operates as an online retailer of beauty products in the People’s Republic of China. The company offers beauty products, such as cosmetics, skin care, cosmetic applicators, fragrance, and body care products; and beauty products for men, and baby and children.
Marvell Technology Group Ltd. (NASDAQ:MRVL)’s shares dropped -8.56% to $13.14.
Marvell Technology Group Ltd. (MRVL) stated financial results for the first quarter of fiscal year 2016, ended May 2, 2015.
Key First Quarter of Fiscal 2016 Financial Highlights
- Revenue: Q1 FY 2016, $724 Million
- GAAP Net Income: Q1 FY 2016, $14 Million
- GAAP Diluted EPS: Q1 FY 2016, $0.03
- Non-GAAP Net Income: Q1 FY 2016, $71 Million
- Non-GAAP Diluted EPS: Q1 FY 2016, $0.13
- Free Cash Flow: Q1 FY 2016, $44 Million
Second Quarter of Fiscal 2016 Financial Outlook
Marvell’s financial outlook does not comprise the potential impact of future share repurchases, pending litigation matters, business combinations, asset acquisitions or other investments that may be accomplished after May 20, 2015.
- Revenue is predictable to be in the range of $710 Million to $740 Million.
- GAAP Gross Margin is predictable to be in the range of 49.5% +/- 100 bps. Non-GAAP Gross Margin is predictable to be in the range of 50.0% +/- 100 bps.
- GAAP Operating Expenses are predictable to be in the range of $350 Million +/- $10 Million. Non-GAAP Operating Expenses to be in the range of $305 Million +/- $10 Million.
Marvell Technology Group Ltd. designs, develops, and markets analog, mixed-signal, digital signal processing, and embedded and standalone integrated circuits. It offers mobile and wireless products comprising communications and applications processors; thin modems; and connectivity solutions, counting Wi-Fi, Bluetooth, near field communication, and FM; and mobile computing products, in addition to silicon solutions and Kinoma software.
At the end of Friday’s trade, Unilife Corp (NASDAQ:UNIS)‘s shares dipped -7.84% to $2.47.
Unilife Corp (UNIS) declared its financial results for the quarter ended March 31, 2015 (“the third quarter of Fiscal Year 2015″, “3Q FY15″ or “Current Quarter”).
Business Highlights
- On January 20, 2015, Unilife filed a Form 8-K regardinga definitive global planned agreement with a global biopharmaceutical company for the customization and supply of its injectable drug delivery systems for use with the customer’s drug portfolio. The customer paid $5 million for the exclusive right to form and enter into a mutually agreeable development and supply agreement with Unilife to comprise exclusive access to the Unifill Finesse™ prefilled syringe and the LISA™ reusable auto-injector for target therapies within the customer’s drug portfolio for the treatment of autoimmune diseases, in addition to associated exclusivity fees.
- As formerly declared, David Hastings joined the Company on February 23, 2015, as Chief Financial Officer. Mr. Hastings most recently served as Chief Financial Officer at Incyte Corporation from 2003 to 2014. In April 2015, Unilife also declared the appointment of Richard L. Beckman, M.D. to the position of Senior Vice President and Chief Medical Officer.
Unilife Corporation designs, manufactures, and supplies injectable drug delivery systems in the United States and internationally. The company offers Unifill, a pre-filled syringe with integrated, automatic, and user-controlled retraction; Unifill Finesse, an integrated, automatic, and user-controlled retraction with standard plunger seal and plunger rod; Unifill Select, which allows an end-user to select and attach a needle at the time of injection; Unifill Nexus that is equipped with an integrated luer adapter to provide connectivity with needleless luer access devices; and Unifill Allure, which combines universal luer connectivity with automatic, user-controlled needle retraction.
Walter Energy, Inc. (NYSE:WLT), ended its Friday’s trading session with -9.4% loss, and closed at $0.479.
Walter Energy, Inc. (WLT) declared that on May 15 it will be making interest payments under its indenture agreements with holders of its 9.5% Senior Secured Notes due in 2019 and the 8.5% Senior Notes due in 2021.
The Company formerly had exercised the 30-day payment grace period as it worked with its debtholders to explore alternatives to recapitalize its balance sheet in light of what has been a challenging met coal pricing environment. The Company will continue to engage in such talk about.
Walter Energy, Inc. produces and exports metallurgical coal for the steel industry. It operates through two segments, U.S. Operations, and Canadian and U.K. Operations. The company also extracts, processes, markets, and/or possesses mineral reserves of thermal coal and anthracite coal, in addition to produces metallurgical coke and coal bed methane gas.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should might occur.
